WO2012030786A3 - Canine bocavirus sequences and uses thereof - Google Patents

Canine bocavirus sequences and uses thereof Download PDF

Info

Publication number
WO2012030786A3
WO2012030786A3 PCT/US2011/049671 US2011049671W WO2012030786A3 WO 2012030786 A3 WO2012030786 A3 WO 2012030786A3 US 2011049671 W US2011049671 W US 2011049671W WO 2012030786 A3 WO2012030786 A3 WO 2012030786A3
Authority
WO
WIPO (PCT)
Prior art keywords
canine
bocaviruses
sequences
bocavirus
animal
Prior art date
Application number
PCT/US2011/049671
Other languages
French (fr)
Other versions
WO2012030786A2 (en
Inventor
W. Ian Lipkin
Amit Kapoor
Original Assignee
The Trustees Of Columbia University In The City Of New York
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Trustees Of Columbia University In The City Of New York filed Critical The Trustees Of Columbia University In The City Of New York
Publication of WO2012030786A2 publication Critical patent/WO2012030786A2/en
Publication of WO2012030786A3 publication Critical patent/WO2012030786A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14311—Parvovirus, e.g. minute virus of mice
    • C12N2750/14321—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14311—Parvovirus, e.g. minute virus of mice
    • C12N2750/14322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The invention is directed to a isolated a canine bocaviruses associated with canine respiratory and gastrointestinal disease, and isolated nucleic acids sequences and polypeptides thereof. The invention also relates to antibodies against antigens from canine bocaviruses. The invention also relates to iRNAs which target nucleic acid sequences of the canine bocavirus. The invention is related to methods for detecting the presence or absence of canine bocaviruses in an animal. The invention is also related to immunogenic compositions for inducing an immune response against canine bocaviruses in an animal.
PCT/US2011/049671 2010-08-30 2011-08-30 Canine bocavirus sequences and uses thereof WO2012030786A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37821310P 2010-08-30 2010-08-30
US61/378,213 2010-08-30

Publications (2)

Publication Number Publication Date
WO2012030786A2 WO2012030786A2 (en) 2012-03-08
WO2012030786A3 true WO2012030786A3 (en) 2012-07-12

Family

ID=45773472

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2011/049671 WO2012030786A2 (en) 2010-08-30 2011-08-30 Canine bocavirus sequences and uses thereof

Country Status (1)

Country Link
WO (1) WO2012030786A2 (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090297557A1 (en) * 2008-04-17 2009-12-03 Blood Systems, Inc. Human parvovirus: bocavirus

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090297557A1 (en) * 2008-04-17 2009-12-03 Blood Systems, Inc. Human parvovirus: bocavirus

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
DATABASE GENBANK 30 November 2004 (2004-11-30), OHSHIMA ET AL.: "Minute virus of canines DNA, complete genome, strain:HM-6.", retrieved from http://www.ncbi.nlm.nih.gov/nuccore/AB158475 accession no. B158475. *
DATABASE UNIPROT 22 July 2008 (2008-07-22), SCHWARTZ, D. ET AL., retrieved from http://www.uniprot.org/uniprot/Q8QQV7.txt?version=21 accession no. 8QQV7 *
MOCHIZUKI ET AL.: "Virologic and Serologic Identification of Minute Virus of Canines (Canine Parvovirus Type 1) from Dogs in Japan.", JOURNAL OF CLINICAL MICROBIOL., vol. 40, no. 11, November 2002 (2002-11-01), pages 3993 - 3998 *
OHSHIMA ET AL.: "Sequence Analysis of an Asian Isolate of Minute Virus of Canines (Canine Parvovirus Type 1).", VIRUSES GENES., vol. 29, no. 3, 2004, pages 291 - 296, XP019216230, DOI: doi:10.1007/s11262-004-7430-3 *
SUN ET AL.: "Molecular Characterization of Infectious Clones of the Minute Virus of Canines Reveals Unique Features of Bocaviruses.", JOURNAL OF VIROLOGY., vol. 83, no. 8, April 2009 (2009-04-01), pages 3956 - 3967 *

Also Published As

Publication number Publication date
WO2012030786A2 (en) 2012-03-08

Similar Documents

Publication Publication Date Title
WO2016100328A8 (en) Novel tilapia virus and uses thereof
WO2012027365A3 (en) Targeted multi-epitope dosage forms for induction of an immune response to antigens
WO2014009438A3 (en) Mycobacterial antigen vaccine
EA200801907A1 (en) Chimeric adenoviral vectors, immunogenic compositions thereof, methods of inducing an immune response with its help immunogenic composition TLR-3 agonist and a vector expression of heterologous proteins, METHOD OF INDUCTION OF IMMUNE RESPONSE BY TLR-3 agonist and a vector expression of heterologous proteins and nucleic acid isolation
EP4303229A3 (en) Enhanced antigen presenting ability of car t cells by co-introduction of costimulatory molecules
WO2012106377A3 (en) Nucleic acid molecules encoding novel herpes antigens, vaccine comprising the same, and methods of use thereof
CL2013001124A1 (en) Isolated antibody or a protein comprising an antigen binding portion of an antibody directed against a cd40 polypeptide; pharmaceutical composition comprising said antibody; nucleic acid encoding the antibody; cloning vector; antibody production process.
MX348071B (en) Fc variants.
HK1215954A1 (en) Btnl9 proteins, nucleic acids, and antibodies and uses thereof btnl9
CY1120430T1 (en) RECOMMENDED CDV COMPOSITIONS AND USES OF THESE
EP3266464A3 (en) Yeast-based therapeutic for chronic hepatitis b infection
WO2013054199A3 (en) Cmv antigens and uses thereof
EA201400912A1 (en) RECOMBINANT POXVIRUS VECTORS, EXPRESSING PROTEINS OF THE RABOR AND OX40 VIRUS, AND VACCINES ESTABLISHED ON THEIR BASIS
WO2012064836A9 (en) Methods and compositions for neural disease immunotherapy
WO2013110818A3 (en) Immunogens for hiv vaccination
WO2015052543A3 (en) Malaria vaccination
WO2009117116A3 (en) Heat shock protein gp96 vaccination and methods of using same
IL213189A (en) Vaccine comprising avian influenza antigen, method of vaccinating an animal therewith, dna encoding the antigen and uses thereof
MX2013007918A (en) Monomeric and multimeric immunogenic peptides.
EP3156070A3 (en) Newcastle disease virus vectored herpesvirus vaccines
EP2582849A4 (en) Detection of nucleic acids and proteins
WO2011156467A3 (en) Methods of detecting residual amounts of polymers used in the purification of biomolecules
IN2015DN02479A (en)
WO2012018907A3 (en) Polypeptides for treating and/or limiting influenza infection
WO2014153168A3 (en) Porcine astrovirus sequences and uses thereof

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11822467

Country of ref document: EP

Kind code of ref document: A2

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11822467

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 11822467

Country of ref document: EP

Kind code of ref document: A2